retatrutide phase 2 trial dosing schedule VisualAbstract: reduces body weight by 17.5% in patients with obesity Triple hormone receptor agonist retatrutide

It is an oral formulation of semaglutide, making it easier to administer

You grab whatever's convenient, then feel guilty about derailing your progress again

Vanessa Mack (Dean) and our skilled team, Semaglutide GLP-1 shots work to control appetite, enhance metabolism, and support sustainable weight loss

Nausea and GI symptoms peak at weeks 6-8, then improve substantially by week 12

Once daily injectable liraglutide (marketed as Victoza for T2DM and Saxenda for obesity) and once weekly injectable semaglutide (marketed as Ozempic for T2DM and Wegovy for obesity) are two additional GLP-1 analogues, sharing 97% and 94% amino acid homology to GLP-1, respectively [ Figure 2 , Table 1 ]

Patients might experience nausea, vomiting and even diarrhea